Serotonergic neurotransmission in prefrontal cortex (PFC) has long been known to play a key role in regulating emotion and cognition under normal and pathological conditions. However, the cellular mechanisms by which this regulation occurs are unclear. In this study, we examined the impact of serotonin on GABA A receptor channels in PFC pyramidal neurons using combined patch-clamp recording, biochemical, and molecular approaches. Application of serotonin produced a reduction of postsynaptic GABA A receptor currents. Although multiple 5-HT receptors were coexpressed in PFC pyramidal neurons, the serotonergic modulation of GABA-evoked currents was mimicked by the 5-HT 2 -class agonist (Ϫ)-2,5-dimethoxy-4-iodoamphetamine and blocked by 5-HT 2 antagonists risperidone and ketanserin, indicating the mediation by 5-HT 2 receptors. Inhibiting phospholipase C blocked the 5-HT 2 inhibition of GABA A currents, as did dialysis with protein kinase C (PKC) inhibitory peptide. Moreover, activation of 5-HT 2 receptors in PFC slices increased the in vitro kinase activity of PKC toward GABA A receptor ␥2 subunits. Disrupting the interaction of PKC with its anchoring protein RACK1 (receptor for activated C kinase) eliminated the 5-HT 2 modulation of GABA A currents, suggesting that RACK1-mediated targeting of PKC to the vicinity of GABA A receptors is required for the serotonergic signaling. Together, our results show that activation of 5-HT 2 receptors in PFC pyramidal neurons inhibits GABA A currents through phosphorylation of GABA A receptors by the activation of anchored PKC. The suppression of GABAergic signaling provides a novel mechanism for serotonergic modulation of PFC neuronal activity, which may underlie the actions of many antidepressant drugs.
Serotonin is a powerful modulator of emotional processes in the CNS. Dysfunction of serotonergic neurotransmission has long been implicated in the pathogenesis of neuropsychiatric disorders, including schizophrenia, depression, and anxiety (Breier, 1995; Dubovsky and Thomas, 1995; Abi-Dargham et al., 1997; Stockmeier, 1997) . Many effective drugs for these disorders act primarily on the serotonin system (Fuxe et al., 1983; Deakin, 1988; Griebel, 1995; Meltzer, 1995; Kapur and Remington, 1996; Busatto and Kerwin, 1997; Lieberman et al., 1998) . One of the main target structures of the serotonergic system is prefrontal cortex (PFC), a brain region associated with high-level, "executive" processes needed for complicated goal-directed behavior (Goldman-Rakic, 1995; Miller, 1999) . PFC is composed of two major neuronal populations: glutamatergic pyramidal principal neurons and GABAergic interneurons. The axon terminals of local GABAergic neurons form numerous synapses with pyramidal projection neurons (Somogyi et al., 1983) , exerting powerful inhibitory control over the excitatory output of PFC. Serotonergic projections target both types of PFC neurons in a synaptic and nonsynaptic manner (Smiley and Goldman-Rakic, 1996) . Specific changes of the PFC serotonin system and PFC neuronal activity that are found in patients with neuropsychiatric disorders (Breier, 1995; Dubovsky and Thomas, 1995; Sumiyoshi et al., 1996; AbiDargham et al., 1997; Stockmeier, 1997; Dean et al., 1999; Meyer et al., 1999) suggest that serotonin plays a crucial and unique role in PFC.
Molecular cloning experiments have identified at least 13 G-protein-coupled serotonin receptor subtypes, which can be grouped into several classes based on their distinct downstream signal transduction pathways. Serotonin can have both inhibitory and excitatory functions in neuronal networks through the coupling of different 5-HT receptors to distinct ion channels (for review, see Andrade, 1998) . Mice lacking serotonin receptors show phenotypes ranging from epilepsy syndrome (Tecott et al., 1995) to increased impulsive aggression (Saudou et al., 1994) to elevated anxiety and antidepressant-like response (Heisler et al., 1998) . Because GABA A receptor-mediated inhibitory synaptic transmission is highly involved in epilepsy, anxiety, and depression (Macdonald and Olsen, 1994) , it suggests that the phenotypes in 5-HT receptor knock-out mice may be correlated with changes in GABAergic transmission of PFC neurons. Furthermore, selective alterations in GABA A receptors, GABA content, and GABAergic local circuit neurons have been discovered in PFC of patients with mental disorders (Benes et al., 1996; Dean et al., 1999; Ohnuma et al., 1999; Lewis, 2000) . These findings led us to speculate that one potential cellular substrate of serotonin in PFC is the GABA A receptor, and dysregulation of GABAergic transmission by serotonin in PFC is an etiological factor in neuropsychiatric diseases. To test this hypothesis, we examined the impact of serotonin on postsynaptic GABA A receptor-mediated currents in dissociated PFC pyramidal neurons. Our results may provide the molecular and cellular mechanisms for serotonergic regulation of inhibitory synaptic transmission in PFC slices, as well as a framework within which the role of serotonin in normal mental functions and neuropsychiatric disorders can be better understood.
MATERIALS AND METHODS
Acute-dissociation procedure. PFC neurons from young adult (3-5 weeks postnatal) rats were acutely dissociated using procedures similar to those described previously . In brief, rats were anesthetized and decapitated; brains were quickly removed, iced, and then blocked for slicing. The blocked tissue was cut in 400 m slices with a vibratome while bathed in a low C a 2ϩ (100 M), H EPES-buffered salt solution [in mM: 140 Na isethionate, 2 KC l, 4 MgC l 2 , 0.1 CaCl 2 , 23 glucose, and 15 H EPES, pH 7.4 (300 -305 mOsm / l)]. Slices were then incubated for 1-6 hr at room temperature (20 -22°C) in NaHC O 3 buffered saline bubbled with 95% O 2 , 5% CO 2 (in mM): 126 NaC l, 2.5 KC l, 2 CaCl 2 , 2 MgC l 2 , 26 NaHC O 3 , 1.25 NaH 2 PO 4 , 1 pyruvic acid, and 10 glucose, pH 7.4 with NaOH (300 -305 mOsm / l). All reagents were purchased from Sigma (St. L ouis, MO).
Slices were then removed into the low C a 2ϩ buffer, and regions of the PFC were dissected and placed in an oxygenated C ell-Stir chamber (Wheaton Inc., Millville, NJ) containing pronase (1-3 mg /ml) in H EPES-buffered HBSS (Sigma) at 35°C. After 20 -30 min of enzyme digestion, tissue was rinsed three times in the low C a 2ϩ , H EPESbuffered saline and mechanically dissociated with a graded series of fire-polished Pasteur pipettes. The cell suspension was then plated into a 35 mm L ux Petri dish, which was then placed on the stage of an inverted microscope.
W hole-cell recordings. Whole-cell recordings of GABA-activated currents used standard techniques (Surmeier et al., 1995; Yan and Surmeier, 1997) . Electrodes were pulled from Corning 7052 glass (A-M Systems Inc., C arlsberg, WA) and fire-polished before use. The internal solution consisted of (in mM): 180 N-methyl-D-glucamine, 40 H EPES, 4 MgC l 2 , 0.5 BAP TA, 12 phosphocreatine, 2 Na 2 ATP, 0.2 Na 3 GTP, and 0.1 leupeptin, pH 7.2-3 with H 2 SO 4 (265-270 mOsm / l). The external solution consisted of (in mM): 135 NaC l, 20 C sC l, 1 MgC l 2 , 10 H EPES, 0.001 TTX, 5 BaCl 2 , and 10 glucose, pH 7.3 with NaOH (300 -305 mOsm / l).
Recordings were obtained with an Axon Instruments 200 patch-clamp amplifier that was controlled and monitored with a I BM personal computer running pC lamp (version 8.1) with a DigiData 1320 series interface (Axon instruments, Foster C ity, CA). Electrode resistances were typically 2-4 M⍀ in the bath. After seal rupture, series resistance (4 -10 M⍀) was compensated (70 -90%) and periodically monitored. The cell membrane potential was held at 0 mV. GABA (100 M) was applied briefly (2-3 sec) every minute. Drugs were applied with a gravity-fed "sewer pipe" system. The array of application capillaries (ϳ150 m inner diameter) was positioned a few hundred micrometers from the cell under study. Solution changes were effected by altering the position of the array with a DC drive system controlled by a microprocessor-based controller (Newport, Irvine, CA).
Serotonin receptor ligands [serotonin, (Ϫ)-2,5-dimethoxy-4-iodoamphetamine (R(Ϫ)-DOI), 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT), methysergide, risperidone, ketanserin, and cyanopindolol (Sigma)] were made freshly on the day of experiments. Second messenger reagents U73122, U74133 (C albiochem, San Diego, CA), heparin (Sigma), phorbol-12-myristate-13-acetate (PM A), and 4␣-phorbol, PKC 19 -31 (Alexis Biochemical Co., San Diego, CA) were made up as concentrated stocks in water or DMSO and stored at Ϫ20°C. Stocks were thawed and diluted immediately before use. The amino acid (aa) sequence for the PKC anchoring inhibitory peptide R ACK1 (receptor for activated C kinase)-rV I is DGGDII NALCFSPN R. The amino acid sequence for the scrambled peptide sR ACK1-rV I is F DSRGIGPDI NCANL. The amino acid sequence for the PKC anchoring inhibitory peptide AKAP is KASMLCFKRRKKAAKLAKPKAG.
Data analyses were performed with AxoGraph (version 3.0; Axon Instruments), Kaleidagraph (version 3.0.4; Albeck Software, Reading, PA), and Statview (version 4.5; Abacus Concepts, C alabasas, CA). Box plots were used for graphic presentation of the data because of the small sample sizes (T ukey, 1977) . The box plot represents the distribution as a box with the median as a central line and the hinges as the edges of the box. The inner fences run to the limits of the distribution excluding outliers. For analysis of statistical significance, paired t tests were performed to compare the differential degrees of current inhibition between groups subjected to different treatment.
Single-neuron mR NA profiling. For the detection of serotonin receptor mRNAs in PFC pyramidal neurons, we used the single-cell reverse transcription (RT)-PCR technique similar to those described previously Surmeier, 1996, 1997) . A patch electrode was used to lift a dissociated neuron into a stream of control solution, and then the neuron was aspirated into the electrode by applying negative pressure. After aspiration, the electrode was broken, and the contents were ejected into a 0.5 ml Eppendorf tube containing 5 l of diethylpyrocarbonate-treated water, 0.5 l of RNAsin (28 U/l), 0.5 l of dithiothreitol (DTT) (0.1 M), and 1 l of oligo-dT primer (0.5 g/l). The mixture was heated to 70°C for 10 min and then incubated on ice for Ͼ1 min. Single-strand cDNA was synthesized from the cellular mRNA by adding SuperScript II reverse transcriptase (1 l, 200 U/l) and buffer [4 l, 5ϫ first-strand buffer (in mM): 250 Tris-HC l, 375 KC l, and 15 MgC l 2 ], RNAsin (0.5 l, 28 U/l), DTT (1.5 l, 0.1 M), and mixed dN TPs (1 l, 10 mM each). The reaction mixture (20 l) was incubated at 42°C for 50 min. The reaction was terminated by heating the mixture to 70°C for 15 min and then icing. The RNA strand in the RNA-DNA hybrid was then removed by adding 1 l of RNase H (2 U/l) and incubating for 20 min at 37°C. All reagents were obtained from Life Technologies (Grand Island, N Y) .
The cDNA from the RT of RNA in single PFC neurons was amplified with the PCR, which was performed with a thermal cycler (MJ Research Inc., Watertown, M A) in thin-walled plastic tubes. Reaction mixtures contained 2-2.5 mM MgC l 2 , 0.5 mM each of the dN TPs, 0.8 -1 M primers, 2.5 U Taq DNA polymerase (Promega, Madison, W I), 5 l of 10ϫ buffer (Promega), and one-fourth (5 l) of the cDNA template made from the single cell RT reaction. The thermal cycling program for the first-round amplification was as follows: 94°C for 1 min, 52°C for 1 min, and 72°C for 1.5 min for 30 cycles. T wo microliters of the first-round PCR product was used as the cDNA template for the second-round amplification: 94°C for 1 min, 56°C for 1 min, and 72°C for 1.5 min for 45 cycles. Ten microliters of the second-round PCR product was separated by electrophoresis in ethidium bromide-stained 1.5% agarose gels. Negative controls for contamination from extraneous and genomic DNA were run for every batch of neurons. The tissue RT-PCR procedure was used to detect mRNAs in PFC.
PCR primers were designed based on GenBank sequences for serotonin receptors. The primers used to amplif y GAD67 (GABA synthesizing enzyme glutamic acid decarboxylase) mRNA were as follows: 5Ј-CAGACAAGCAGTATGACGTC TCC T and 5Ј-AGGAAATCGATG-TCAGAC TGGGTG. The size of GAD67 amplicon was 435 bp. One round (45 cycle) of PCR amplification was performed for the detection of GAD mRNA. T wo rounds of nested PCR amplification were performed for the detection of 5-HT receptor mRNAs. The outer primers used to amplif y 5-HT 1A /1D and 5-HT 1B receptors were as follows: 5Ј-AAC -TATC TCATYGGC TCC; 5Ј-CAGCCAGCAGAKGATR AA; 5Ј-TA-AC TACC TGATCGCC TC; and 5Ј-GAGCCAGCACACAATAAA. The outer primers used to amplif y 5-HT 2A /2C receptors were 5Ј-GCCATWGC TGATATGC TG and 5Ј-CCASACAAACACATTGAG. The outer primers used to amplif y 5-HT 4 receptors were 5Ј-ACAAGAT GACCCC TC TAC and 5Ј-TAGCGC TCATCATCACAG. The outer primers used to amplif y 5-HT 6 and 5-HT 7 receptors were as follows: 5Ј-C TTCACGTCGGAC TTGAT; 5Ј-TGTGAGGACATCGAAGAG; 5Ј-CGGTCATGCCTTTCGTTA; and 5Ј-ATATTCCGGTACTGGCAC.
The specific inner primers for 5-HT 1A were 5Ј-TC TGTACCAGGT-GC TCAACAAG and 5Ј-AGAGGAAGGTGC TC TTTGGAGT. The size of 5-HT 1A amplicon was 638 bp. The specific inner primers for 5-HT 1B were 5Ј-ATCAGCACCATGTACACGGTCA and 5Ј-GAC T-TGGTTCACGTACACAGGA. The size of 5-HT 1B amplicon was 557 bp. The specific inner primers for 5-HT 1D were 5Ј-AGATGTC T-GAC TGCC TGGTGAA and 5Ј-TGCGTTC TAAGATGC TATCAGC. The size of 5-HT 1D amplicon was 316 bp. The specific inner primers for 5-HT 2A were 5Ј-ATTGCCGTGTGGACCATATC TG and 5Ј-GCAGG-ATTC TTTGCAGATGACG. The size of 5-HT 2A amplicon was 460 bp. The specific inner primers for 5-HT 2C were 5Ј-GCCATCATGAAGA-TTGCCATCG and 5Ј-CGACGTGGTTTC TGATC TGGAT. The size of 5-HT 2C amplicon was 358 bp. The specific inner primers for 5-HT 4 were 5Ј-CCCATAATGCAAGGC TGGAACA and 5Ј-GGAAGGCAC -GTC TGAAAGAC TT. The size of 5-HT 4 amplicon was 504 bp. The specific inner primers for 5-HT 6 were 5Ј-AGCCATGC TGAACG-CGC TGTAT and 5Ј-CAAGGCC TTCC TGC TATGC TTG. The size of 5-HT 6 amplicon was 546 bp. The specific inner primers for 5-HT 7 were 5Ј-CCAC TTC TTC TGCAACGTC TTC and 5Ј-GTGTTTGAGCAG-TC TCGAAAGG. The size of 5-HT 7 amplicon was 480 bp.
Protein k inase assay. Brain slices were incubated with the 5-HT 2 receptor agonist DOI or PM A for 20 min and then lysed in cold lysis buffer (0.5% Nonidet P-40, 0.1 mM EDTA, 50 mM Tris-HC l, 125 mM NaC l, 0.1 mM Na 3 VO 4 , 50 mM NaF, and 1 mM phenylmethylsulfonyl fluoride) on ice for 30 min. Brain lysates were centrif uged and ultracentrif uged, and PKC was immunoprecipated with rabbit polyclonal anti-PKC␣␤␥ (Life Technologies) for 1 hr, followed by the addition of 50 l of protein A Sepharose beads and incubation for 1 hr at 4°C. The beads were pelleted by centrif ugation and washed three times with lysis buffer and three times with kinase buffer (50 mM Tris-HC l pH 7.5, and 5 mM MgC l 2 ) and then resuspended in 30 l of kinase buffer. In vitro kinase activity was measured in the PKC immunoprecipitates using peptides derived from GABA A receptors as substrates. The intracellular regions between the third and the fourth transmembrane domain of GABA A receptor ␤2 and ␥2 subunits contain identified PKC phosphorylation sites. The sequences for the two peptides against these regions are as follows: GABA A -␤2, K SRLRRR ASQL K I TI (amino acids 402-416 in mature ␤2 protein without the 24 aa signal peptide); and GABA A -␥2, SNRKPSKDKDKKKKNPAPT (amino acids 322-340 in mature ␥2 protein without the 38 aa signal peptide). The assay was initiated by the addition of 5 l of [␥-
32 P]ATP (10 mC i /ml) and 1 l of peptide (10 mg /ml), continued for 20 min at room temperature, and stopped by boiling samples in SDS-PAGE sample buffer. In some cases, 1 l of the myristoylated PKC inhibitory peptide PKC 19 -31 (10 mg /ml; Promega) was added to the reaction mixture. Samples were loaded onto a 20% polyacrylamide gel and subjected to electrophoresis. The gels were vacuum dried and exposed to Biomax film (Eastman Kodak, Rochester, N Y). K inase activity was quantified by an phosphoimager.
RESULTS

Serotonin reduces GABA-activated currents in PFC pyramidal neurons
In rats, the prelimbic, infralimbic, and ventral anterior cingulate cortex represent the major subdivisions of PFC (Groenewegen, 1988) . Based on their patterns of neural connectivity, these regions are thought to be functionally related to PFC in the primate (Kolb, 1984; Uylings and van Eden, 1990; Conde et al., 1995) . To test the potential impact of serotonin on GABAergic signaling, we examined the effect of serotonin on GABA A receptormediated currents in pyramidal neurons located in the intermediate and deep layers (III-VI) of the rat PFC. GABA was applied to these neurons that were voltage clamped using whole-cell techniques. The application of GABA (100 M) evoked a partially desensitizing outward current with the decay rate fitted by a single or double exponential. This current was completely blocked by the GABA A receptor antagonist bicuculline (30 M, n ϭ 3; data not shown), confirming mediation by the GABA A receptor. Application of serotonin (20 M) caused a reduction in the amplitudes of GABA A currents in ϳ90% of PFC pyramidal neurons tested (n ϭ 21). Shown in Figure 1 A is a plot of peak currents evoked by repeated application of GABA (100 M) as a function of time. GABA was applied once per minute for 2-3 sec to minimize desensitization-induced decrease of current amplitude. The serotonergic reduction of GABA A currents had slow onset kinetics, taking 3-4 min to stabilize. The modulation was not accompanied by changes in current decay kinetics. The median reduction of peak GABA A currents by serotonin was 25.4% (n ϭ 21) (Fig. 1 B) . This serotonin-mediated inhibition of GABA A currents did not result from an agonist-independent run-down of the current, because no significant decrease of the current was observed in the absence of serotonin (Fig. 1 A) . Application of the nonselective 5-HT receptor antagonist methysergide (10 M) primarily abolished the inhibition, and washing off the antagonist led to recovery of 5-HT effect on GABA A currents (Fig. 1C,D) . As shown in Figure 1C , inset, 70-90% of serotonergic inhibition of GABA A currents was blocked by methysergide (n ϭ 8), confirming that this effect is mediated by 5-HT receptors.
PFC pyramidal neurons express multiple 5-HT receptor mRNAs
To test which 5-HT receptor may mediate the serotonergic inhibition of GABA A currents, we first examined the expression of 5-HT receptor mRNAs in PFC neurons. The mRNAs for 5-HT 1 (5-HT 1A, 1B, 1D ), 5-HT 2 (5-HT 2A, 2C ), 5-HT 4 , 5-HT 6 , and 5-HT 7 receptors were first detected with cDNA obtained from the whole PFC tissue. As shown in Figure 2 A, all of these receptor subtypes are present in this brain region. Because PFC is composed of heterogeneous neuronal populations, it is important to determine how serotonin receptors are coordinately expressed in individual PFC pyramidal neurons. Cells were harvested after recording and analyzed using the single-cell RT-PCR technique Surmeier, 1996, 1997) . Acutely isolated PFC pyramidal neurons were readily distinguished from GABAergic interneurons by their distinct morphological features: a pyramidal-shaped soma and a prominent apical dendrite. The expression of GAD mRNA was consistently negative in the harvested neurons (data not shown), confirming that they are not GABAergic interneurons. For the detection of 5-HT receptor subtypes, a two-stage PCR amplification protocol was used to minimize problems associated with The starting point for continuous application of serotonin is marked by the arrow. Application of serotonin caused an inhibition of GABA A receptor currents, whereas repeated application of GABA alone evoked a current that was stable during the whole-cell recording. B, Box plot summary of the percentage of reduction of peak GABA A currents produced by serotonin in a sample of 21 PFC pyramidal neurons. C, Plot of peak GABA A current as a function of time and ligand application. In the presence of the nonselective 5-HT receptor antagonist methysergide (meth; 10 M), serotonin had little effect on GABA A currents; washing off the antagonist led to recovery of the serotonin inhibition (wash). The inset is a box plot summary showing the percentage of serotonin effect blocked by methysergide (n ϭ 8). D, Representative current traces taken from the records used to construct C (at time points denoted by *). template abundance. In the first round of amplification, each family of subunits was amplified using degenerate primer sets. In the second round, subunit-specific "nested" primers were used.
A representative picture of an acutely dissociated PFC pyramidal neuron is shown in Figure 2 B. The mRNA profile for 5-HT receptor subtypes of this cell is shown in Figure 2C . The 5-HT 1A , 5-HT 2A , and 5-HT 4 receptor mRNAs were coexpressed in this neuron. In 26 individual PFC pyramidal neurons tested, nearly all of them expressed the 5-HT 1A receptor mRNA (24 of 26). Approximately 60% of these cells expressed the 5-HT 1B receptor mRNA (15 of 26). A large portion of these cells expressed the 5-HT 2A receptor mRNA (21 of 26), whereas the 5-HT 2C receptor mRNA was detected in only one-third of these cells (9 of 26). The 5-HT 4 receptor mRNA was found in ϳ60% of these cells (16 of 26). Other 5-HT receptor subtype mRNAs (e.g., 5-HT 1D , 5-HT 6 , and 5-HT 7 ) were rarely detected (Ͻ10%). The coordinated expression of major 5-HT receptor mRNAs in the sample of 26 PFC pyramidal neurons is summarized in Figure 2 D, from which several coexpression patterns of 5-HT receptors detectable in individual cells could be seen. For example, the simultaneous mRNA expression of all five subtypes (5-HT 1A , 1B , 2A , 2C , 4 ) was detected in 5 of 26 neurons, and coexpression of four subtypes (5-HT 1A , 1B , 2A , 4 ) was detected in 4 of 26 neurons. A subset of neurons (7 of 26) had detectable mRNA levels of three subtypes (5-HT 1A , 2A , 4 ), and other neurons (4 of 26) had only two subtypes (5-HT 1A , 2A ). The coordinated expression of mRNAs encoding multiple 5-HT receptor subtypes suggests that 5-HT could regulate PFC functions by simultaneously activating distinct signaling cascades mediated by these receptors.
Serotonergic modulation of GABA-activated currents is mediated by 5-HT 2 receptors
Because multiple 5-HT receptors are simultaneously expressed in individual PFC pyramidal neurons, we next used subtype-specific agonists and antagonists to examine which 5-HT receptor was involved in the modulation of GABA A currents. 5-HT 1A and 5-HT 2A are the most prominent serotonin receptor subtypes expressed in PFC pyramidal neurons, so we first examined the potential role of these receptors in the modulation of GABA A currents. In eight PFC pyramidal neurons tested, GABA A currents were not affected by the 5-HT 1A receptor agonist 8-OH-DPAT (20 M; data not shown), suggesting that the serotonergic effect on GABA A channels was not mediated by the 5-HT 1A receptor. On the other hand, application of the 5-HT 2A /C receptor agonist DOI (10 M) caused a reduction (27.1 Ϯ 10.6%, mean Ϯ SD; n ϭ 24) in the amplitudes of GABA A currents without affecting the time constants for current decay in most of the PFC pyramidal neurons tested (87.5%) (Fig. 3 A, B) , mimicking the inhibitory effect of 5-HT. Washing off DOI led to a partial or complete recovery of GABA A currents. To verify that 5-HT 2A /C receptors were mediating the modulation seen with DOI or 5-HT, the ability of 5-HT 2 -class antagonist risperidone (Baxter et al., 1995) to prevent the action of DOI or 5-HT was examined. As shown in Figure 3C , risperidone (10 M) almost completely eliminated the effects of DOI (10 M). Removing the antagonist restored the ability of DOI to modulate GABA A currents. The median reduction of peak GABA A currents by DOI was 25.1% (n ϭ 24) (Fig. 3D) , similar to the 5-HT effect (median reduction of 25.4%; n ϭ 21) (Fig. 1 B) . In the presence of risperidone, the inhibition of GABA A currents by DOI (n ϭ 10) or 5-HT (n ϭ 6) was both significantly blocked (median reduction of 7.8 and 5.8%, respectively) (Fig. 3D) . Because risperidone also blocks D 2 dopamine receptors, we further tested the DOI effect in the presence of the selective D 2 antagonist sulpiride. Application of sulpiride (10 M) did not block the inhibitory effect of DOI on GABA A currents (data not shown), suggesting that D 2 receptors were not involved in the action of DOI. Moreover, the DOI or 5-HT effect was greatly attenuated by another 5-HT 2 -class antagonist, ketanserin (median reduction of 6.4%; n ϭ 5) (Fig.  3D ) but was not altered by a 5-HT 1 -class antagonist, cyanopindolol (median reduction of 22.3%; n ϭ 5) (Fig. 3D) . These results suggest that the serotonergic effect on GABA A channels is mediated by 5-HT 2A /C receptors. Our single-cell mRNA profiling experiments have shown that 5-HT 2A receptors are expressed in the majority of PFC pyramidal neurons (Ͼ80%), whereas 5-HT 2C receptors are detected in only one-third of these cells, suggesting that the effects of DOI on GABA A currents found in most PFC pyramidal neurons can be primarily attributed to 5-HT 2A receptors.
5-HT 2 receptors modulate GABA A currents via the phospholipase C ␤ isoform-mediated pathway
We next examined the signal transduction pathways mediating the modulation of GABA A currents by 5-HT 2 receptors. In studies using cell lines, it has been found that activation of 5-HT 2 receptors stimulates phospholipase C ␤ isoform (PLC␤), leading to the release of ionsitol-1,4,5-triphosphate (IP 3 ) and diacylglycerol (DAG) through the hydrolysis of membrane phosphoinositol lipids. To test whether the modulation of GABA A currents by 5-HT 2 receptors is through the PLC␤-mediated pathway, we dialyzed the neuron with the selective PLC␤ inhibitor U73122 and examined the 5-HT 2 effect on GABA A currents under this condition. If the 5-HT 2 agonist was exerting its effect through the phospholipid cascade, then inhibiting PLC␤ should block the effect of receptor activation. In agreement with this model, dialysis with the PLC␤ inhibitor U73122 (4 M) significantly reduced the ability of DOI to inhibit GABA-evoked currents, whereas the inactive analog U74133 (4 M) had no effect. A representative experiment is shown in Figure 4 . The median reduction of peak GABA A currents by DOI was 6.2% in the presence of U73122 (n ϭ 5) (Fig. 4 B) and 27.5% in the presence of U74133 (n ϭ 5; p Ͻ 0.005; paired t test) (Fig. 4 B) . These results indicate that 5-HT 2 receptors modulate GABA A currents through the PLC␤-mediated pathway.
The 5-HT 2 modulation of GABA A currents is dependent on PKC activation
GABA A channels are thought to be heteropentameric structures, composed of different subunits (Macdonald and Olsen, 1994) . Protein phosphorylation exerts a powerful impact on the regulation of GABA-activated currents in recombinant and native GABA A channels (Porter et al., 1990; Kellenberger et al., 1992; Krishek et al., 1994) . Because 5-HT 2 receptors couple to the PLC␤-IP 3 -DAG pathway, which could lead to the activation of PKC, we tested whether the 5-HT 2 -induced reduction of GABA A currents in PFC neurons was mediated by activated PKC. Application of the PKC activator PMA (1 M), but not its inactive analog 4␣-phorbol (1 M), mimicked the serotonergic effect on GABA A channels, causing an irreversible decrease of the amplitude of GABA A currents (Fig. 5A) . The median inhibition was 37.3% by PMA (n ϭ 5) (Fig. 5B) and was only 5.6% by 4␣-phorbol (n ϭ 5; p Ͻ 0.002; paired t test) (Fig. 5B) . If 5-HT 2 receptors were exerting its effect through PKC, then inhibiting the activation of PKC should eliminate the effect of 5-HT 2 on GABA A currents. Because conventional PKC isoforms (PKC␣, PKC␤, and PKC␥) depend on Ca 2ϩ for their activation (Tanaka and Nishizuka, 1994) , we used the IP 3 receptor antagonist heparin (10 U/ml) to block the elevation of intracellular free Ca 2ϩ (Finch et al., 1991; Finch and Augustine, 1998 ) and examined 5-HT 2 modulation of GABA A currents under this condition. As shown in Figure 5C , dialysis with heparin significantly attenuated the effect of DOI on GABA A currents. The median reduction of peak GABA A currents by DOI was 9.1% in the presence of heparin (n ϭ 5) (Fig. 5D) , whereas in control cells DOI reduced GABA A currents by 23.5% (n ϭ 6; p Ͻ 0.005; paired t test) (Fig.  5D ). To further test the involvement of intracellular Ca 2ϩ in 5-HT 2 modulation of GABA A currents, we also dialyzed neurons with a high concentration (10 mM) of BAPTA, a potent and rapid Ca 2ϩ chelator. As shown in Figure 5D , the median reduction of peak GABA A currents by DOI was only 3.8% in the presence of high BAPTA (n ϭ 5), which was significantly smaller than the DOI effect in control cells (n ϭ 6; p Ͻ 0.005; paired t test). These results suggest that 5-HT 2 modulation of GABA A channels requires intracellular Ca 2ϩ . To provide additional evidence for the involvement of PKC, we dialyzed neurons with the PKC inhibitory peptide PKC 19 -31 (20 M). As shown in Figure 5E , PKC 19 -31 blocked the effect of DOI on GABA A currents. The median reduction of peak GABA A currents by DOI was 1.5% in the presence of PKC 19 -31 (n ϭ 6) (Fig. 5F ), which was significantly smaller than the DOI effect in control cells loaded with peptidefree internal solutions (median reduction of 30.5%; n ϭ 5; p Ͻ 0.005; paired t test) (Fig. 5F ). Together, these data show that 5-HT 2 receptor-mediated inhibition of GABA A currents is dependent on PKC activation. 
Activation of 5-HT 2 receptors increases PKC phosphorylation of GABA A receptor ␥2 subunits
Because our electrophysiological experiments have provided strong evidence for the involvement of PKC in 5-HT 2 modulation of GABA A currents, we hypothesize that phosphorylation of GABA A receptors by activated PKC is the underlying molecular mechanism for 5-HT 2 inhibition of GABA A currents. To test this hypothesis, we used biochemical methods to examine whether the activation of 5-HT 2 receptors could enhance PKC phosphorylation of GABA A receptor subunits in PFC networks.
Multiple PKC phosphorylation sites have been identified in GABA A receptor ␥ subunits and ␤ subunits (Macdonald and Olsen, 1994) . Peptides derived from the intracellular regions between the third and the fourth transmembrane domain of GABA A receptor ␤2 and ␥2 subunits, which contain PKC phosphorylation sites that have been characterized previously (Moss et al., 1992) , were used as substrates in in vitro kinase assays. Brain slices containing PFC were treated with or without the 5-HT 2 agonist DOI or the PKC activator PMA, and PKC phosphorylation of these peptides were compared in these slices. As shown in Figure 6 , PKC phosphorylation of the peptide derived from GABA A receptor ␥2 subunit was significantly increased in slices treated with DOI or PMA (Fig. 6 A) . These effects were completely eliminated by including the PKC inhibitory peptide PKC 19 -31 in the in vitro kinase reactions (Fig. 6 B) . In contrast, PKC phosphorylation of the GABA A receptor ␤2 peptide was not significantly altered by DOI or PMA treatment (Fig. 6C) . Equal loading of PKC in the in vitro kinase assay was shown by Western blotting of the PKC immunoprecipitates with an antibody against PKC (Fig. 6 D-F ) . Quantification of three similar experiments showed that DOI increased PKC phosphorylation of the ␥2 peptide by threefold to fourfold, similar to the PMA effect, whereas DOI or PMA treatment did not significantly increase PKC phosphorylation of the ␤2 peptide over the high basal level (Fig. 6G) . These results suggest that activation of 5-HT 2 receptors enhances the kinase activity of PKC, causing increased phosphorylation of GABA A receptor ␥2 subunits.
The 5-HT 2 modulation of GABA A currents requires the anchoring of activated PKC by RACK1
In CNS neurons, ion channels and signaling enzymes are not diffusely located but are compartmentalized to particular subcellular regions by association with various anchoring proteins (Pawson and Scott, 1997). PKC, like other kinases with broad substrate selectivity, achieves the efficacy and specificity of signal transduction through anchoring protein-mediated subcellular targeting to its substrates (Mochly-Rosen, 1995) . PKC has multiple binding proteins (Mochly-Rosen and Gordon, 1998) . One class of proteins that binds only activated PKC isoforms in a selective manner is called RACKs (Mochly-Rosen et al., 1991) . One member of this family of proteins, RACK1, binds to the GABA A receptor intracellular domain (Brandon et al., 1999) . This evidence suggests that RACK1 may be responsible for targeting PKC to GABA A receptor channels and allowing PKC to effectively phosphorylate these receptors. We hypothesize that blocking PKC-RACK1 interaction may lead to the removal of PKC from the vicinity of GABA A receptors, thereby attenuating PKC regulation of these channels. To test this hypothesis, we dialyzed neurons with a PKC anchoring inhibitory peptide. RACK1 contains seven WD40 motifs, an internally repeating element that is thought to be involved in protein-protein interactions. A peptide derived from the sequence within the sixth WD40 repeats of RACK1 has been found to inhibit PKC binding to RACK1 in vitro (Ron et al., 1994) . Based on this result, we synthesized the peptide RACK1-rVI using the sequence from the sixth WD40 repeats of RACK1 and dialyzed the cell with this peptide. As shown in Figure 7 , A and B, dialysis with the PKC anchoring inhibitory peptide RACK1-rVI eliminated the ability of DOI to inhibit GABA A currents, whereas the control peptide with scrambled amino acid sequence had no effect on 5-HT 2 reduction of GABA A currents.
To determine the specific involvement of RACK1 in 5-HT 2 modulation of GABA A currents, we also tested the role of another PKC anchoring protein AKAP79 (Klauck et al., 1996) in this process. AKAP79 is a member of the "PKC substrate- Figure 5 . 5-HT 2 modulation of GABA A currents is dependent on activation of PKC. A, Time course of peak GABA A current in the presence of PMA (1 M) or 4␣-phorbol (1 M). The starting point for continuous application of PMA or 4␣-phorbol is marked by the arrow. The PKC activator PMA caused an irreversible reduction of GABA A receptor currents, whereas the inactive analog 4␣-phorbol had little effect on GABA A currents. B, Box plot summary of the modulation of GABA A currents by PMA (n ϭ 5) or 4␣-phorbol (n ϭ 5). C, Plot of peak GABA A current as a function of time and agonist application with or without heparin (10 U/ml) in the recording pipette. Blocking IP 3 -mediated Ca 2ϩ release with heparin significantly attenuated the effect of DOI on GABA A currents. D, Box plot summary of the modulation of GABA A currents by DOI in the absence (control; n ϭ 6) and presence of heparin (n ϭ 5) or the high concentration (10 mM) of BAPTA (n ϭ 5). E, Plot of peak GABA A current as a function of time and agonist application with or without PKC 19 -31 (20 M) in the recording pipette. Dialysis with the PKC inhibitory peptide PKC 19 -31 blocked the effect of DOI on GABA A currents. F, Box plot summary of the modulation of GABA A currents by DOI in the absence (control; n ϭ 5) and presence of PKC 19 -31 (n ϭ 6).
binding proteins" that could be anchoring proteins for inactive PKC (Mochly-Rosen and Gordon, 1998) . Biochemical studies have shown that residues 31-52 of AKAP79 are the putative PKC binding site (Klauck et al., 1996) . A peptide encompassing this region of AKAP79 specifically blocked the interaction of AKAP79 with PKC in the overlay assay (Klauck et al., 1996) . This peptide, named AKAP[31-52], was dialyzed to PFC pyramidal neurons, and DOI effects on GABA A currents in these cells were measured. As shown in Figure 7C , in the presence of peptide AKAP , DOI still reduced GABA A currents, which was similar to the DOI effect in control cells with no peptide dialyzed (Fig. 3A) . As summarized in Figure 7D , the DOI effect on GABA A currents was significantly smaller in neurons dialyzed with the peptide RACK1-rVI (median reduction of 2.9%; n ϭ 11) compared with neurons dialyzed with the scrambled peptide sRACK1-rVI (median reduction of 25.5%; n ϭ 5; p Ͻ 0.01; paired t test). However, the DOI effect on GABA A currents in neurons dialyzed with the peptide AKAP[31-52] was not significantly different from that in control cells (median reduction of 17.6%; n ϭ 5; p Ͼ 0.05; paired t test). These results suggest that, in PFC pyramidal neurons, serotonergic modulation of GABA A receptors requires the anchoring of activated PKC to the vicinity of the channel by RACK1.
DISCUSSION
Because dysfunction of both serotonin and GABA neurotransmission in PFC has been implicated in mental disorders (Manji et al., 2001 ) and the link between them was unclear, we examined the impact of serotonin on postsynaptic GABA A receptor functions in PFC pyramidal neurons. Our results show that application of serotonin leads to a reduction of GABA A receptor currents, suggesting that activation of serotonin signaling can suppress the GABAergic inhibition in PFC circuits. Indeed, recordings of Lysates of these slices were used for immunoprecipitation with antibodies to PKC␣␤␥. PKC kinase activity of the immune complex was measured using a peptide derived from GABA A ␥2 subunit as the substrate. Application of DOI or PMA enhanced PKC phosphorylation of the GABA A ␥2 peptide. B, Including 1 l of the PKC inhibitory peptide PKC 19 -31 (10 mg/ml) in the in vitro kinase reactions blocked PKC phosphorylation of the GABA A ␥2 peptide induced by DOI or PMA. C, In vitro kinase activity of PKC immunoprecipitates toward a peptide derived from GABA A receptor ␤2 subunit. Lysates of brain slices treated with or without DOI (20 M) or PMA (1 M) were immunoprecipitated with PKC␣␤␥ antibodies, and PKC activity of the immune complex was measured using a GABA A ␤2 subunit peptide as the substrate. Application of DOI or PMA did not significantly alter PKC phosphorylation of the GABA A ␤2 peptide over the high basal level. D-F, Equal loading of PKC in the in vitro kinase assay. Half of the brain lysates used for in vitro kinase assay was immunoprecipitated with PKC␣␤␥ antibodies and Western blotted with PKC␣␤␥ antibodies. G, Histogram summary of the phosphorylation of GABA A receptor ␥2 subunit-derived peptide and ␤2 subunit-derived peptide in PFC slices. Treatment with DOI or PMA significantly increased the phosphorylation of GABA A receptor ␥2 subunit, which was blocked by the PKC inhibitory peptide PKC 19 -31 (left panel; n ϭ 3; *p Ͻ 0.01), but did not significantly enhance the phosphorylation of GABA A receptor ␤2 subunit (right panel; n ϭ 3). pyramidal neurons in frontal cortical slices have shown that 5-HT decreases the amplitude of evoked IPSCs by 20% (Zhou and Hablitz, 1999) . Although 5-HT could increase the excitability of PFC GABAergic interneurons, leading to increased presynaptic release of GABA (Zhou and Hablitz, 1999) , our current study provides evidence showing that 5-HT could also decrease the postsynaptic response to GABA in pyramidal neurons through an intracellular signaling cascade. This suppression of GABAergic inhibition may provide a negative feedback mechanism for serotonergic regulation of the activity of PFC circuits.
To determine which 5-HT receptor(s) may mediate the serotonergic modulation of GABA A receptor currents, we first need to know what 5-HT receptors are expressed in PFC neurons. With the single-cell RT-PCR technique (Lambolez et al., 1992; Monyer and Lambolez, 1995; Surmeier et al., 1996 Surmeier et al., , 1997 Yan and Surmeier, 1996) , mRNAs for multiple 5-HT receptors are found in individual PFC pyramidal neurons. Particularly, 5-HT 1A and 5-HT 2A receptor mRNAs are most frequently detected in these cells, and 5-HT 1B , 5-HT 4 , and 5-HT 2C receptor mRNAs are also present in a subset of them. These results provide a comprehensive "blueprint" for the potential coexpression of 5-HT receptor subtypes in PFC pyramidal neurons. Moreover, our results are consistent with previous anatomical and physiological studies suggesting the possible colocalization of 5-HT 1 and 5-HT 2 receptors in PFC neurons (Goldman-Rakic et al., 1990; Araneda and Andrade, 1991) . The coexpression of multiple 5-HT receptors in the same neuron provides a flexible mechanism by which serotonin may modify the function of PFC in a manner that is both selective and precise (Andrade, 1998) .
With the possible coexpression of multiple 5-HT receptors in PFC pyramidal neurons, selective pharmacological tools have been used to determine the 5-HT receptor(s) involved in serotonergic modulation of GABA A receptors. The serotonin effect on GABA A currents can be mimicked by a 5-HT 2A /2C agonist and blocked by 5-HT 2A /2C antagonists, suggesting that 5-HT 2A /2C receptors play a predominant role in the serotonergic modulation of GABA A channels. Postsynaptic 5-HT 2A receptors are enriched in apical dendrites proximal to the soma in PFC pyramidal neurons (Jakab and Goldman-Rakic, 1998) , whereas GABA A receptors exhibit a compartmentalized distribution on postsynaptic domains of GABAergic synapses on the soma and proximal dendrites (Nusser et al., 1996) , suggesting that 5-HT 2A receptors may be localized in the vicinity of GABA A receptors in PFC pyramidal neurons. This synaptic organization would enable direct serotonergic modulation of local responses to inhibitory input, thereby regulating the integration of the neuron of its myriad inputs and ultimately affecting its output via axonal projections. Intracellular recordings of PFC slices show that activation of 5-HT 2 receptors induces membrane depolarization and a burst of spikes (Araneda and Andrade, 1991; Tanaka and North, 1993) . The 5-HT 2 receptor-mediated reduction of GABAergic inhibition could be one of the potential mechanisms for the excitatory actions of 5-HT 2 receptors in PFC circuits.
Several lines of evidence in the present study show that 5-HT 2 modulation of GABA A receptor currents is through a PKCmediated pathway. First, inhibition of the upstream signaling component PLC␤, which should block the activation of PKC, eliminated 5-HT 2 receptor modulation of GABA A currents. Second, the PKC activator PMA mimicked the 5-HT 2 effect on GABA A currents. Third, the IP 3 receptor antagonist and high BAPTA, which should block the elevation of intracellular Ca 2ϩ and the activation of conventional PKC isoforms, greatly attenuated the ability of 5-HT 2 receptors to modulate GABA A currents. Fourth, the PKC inhibitory peptide, which inhibits both autophosphorylation and substrate phosphorylation, blocked the 5-HT 2 effect on GABA A currents. These physiological results suggest that PKC activation is required for 5-HT 2 modulation of GABA A channels. Because membrane-translocated PKC can be converted into an effector-independent form for sustained activation (Huang, 1989) once the C-terminal sites have been phosphorylated after the activation loop phosphorylation (Newton, 1997; Dutil et al., 1998; Le Good et al., 1998) , 5-HT 2 receptors can elicit physiological effects that are long lasting.
The involvement of PKC led us to speculate that PKC-induced phosphorylation of GABA A receptor channels may be the underlying molecular mechanism for 5-HT 2 modulation of GABA A currents. To test this, we used in vitro kinase assay to examine whether 5-HT 2 receptors can increase PKC phosphorylation of GABA A receptor subunits. Treatment of PFC slices with a 5-HT 2 receptor agonist significantly increased the in vitro kinase activity of PKC toward the peptide derived from GABA A receptor ␥2 subunit, but not the peptide derived from GABA A receptor ␤2 subunit. These results suggest that activation of 5-HT 2 receptors in PFC can enhance the PKC catalytic activity and potentiate PKC phosphorylation of GABA A receptors in a subunit-specific manner. In heterologous expression systems, phosphorylation of Ser-410 in ␤2, Ser-327 in ␥2, and Ser-343 in ␥2L is crucial for PKC-mediated downregulation of GABA currents (Kellenberger et al., 1992; Krishek et al., 1994) , and PKC is much more effective with ␥2-containing GABA A receptors (Krishek et al., 1994) . Consistent with this, our data reveal that increased PKC phosphorylation of Ser-327 in ␥2 subunit by 5-HT 2 signaling may play a major role in mediating the serotonergic modulation of GABA A currents in PFC neurons. Although the ␤2 peptide is strongly phosphorylated in both control (Ϫ) and DOI-treated PFC slices, the lack of additional enhancement of its phosphorylation after 5-HT 2 receptor activation could be attributable to its high basal phosphorylation by endogenous constitutively active PKC.
Given the broad substrate selectivity of PKC, the control of specificity becomes a crucial issue in signal transduction. Subcellular targeting through association with anchoring proteins has emerged as an important mechanism by which signaling enzymes achieve precise substrate recognition and enhanced efficacy of signal transduction (Rosenmund et al., 1994; Gao et al., 1997; Pawson and Scott, 1997; Yan et al., 1999; Feng et al., 2000) . The PKC family is composed of at least 10 isoforms, which are localized in different subcellular compartments to control different functions (Tanaka and Nishizuka, 1994) . Recent studies have revealed the key role played by anchoring proteins in mediating PKC compartmentalization and functions (Mochly-Rosen, 1995; Mochly-Rosen and Gordon, 1998) . RACK1, one member of the RACK family proteins, binds only activated PKC isoforms in a selective manner (Mochly-Rosen et al., 1991) and is strongly associated with neuronal GABA A receptors in in vitro assays (Brandon et al., 1999) . Binding to RACK1 results in augmentation of substrate phosphorylation by PKC, and blocking PKC-RACK1 interaction leads to inhibition of PKC-mediated function (Ron et al., 1994 (Ron et al., , 1995 . In aged rat brain cortex, the expression of RACK1 is significantly reduced, and the RACK1-interacting PKC isoenymes do not translocate from soluble to membrane during stimulation (Battaini et al., 1997) , suggesting that RACK1 is particularly important in cortical functions. To test whether the targeting of activated PKC to GABA A receptors via RACK1 may endow the enzyme to effectively phosphorylate these receptors in vivo, we examined the involvement of RACK1 in serotonergic modulation of GABA A currents in PFC neurons. Dialysis with a RACK1-derived peptide that can specifically disrupt the interaction between RACK1 and PKC (Ron et al., 1994) eliminated the serotonergic modulation of GABA A currents, whereas a peptide that can disrupt the AKAP79 -PKC complex (Klauck et al., 1996) had no effect on serotonergic modulation of GABA A currents. These results suggest that targeting of activated PKC to GABA A receptors via RACK1 is crucial for the regulation of GABA A currents by the 5HT 2 -PKC signaling pathway.
Together, our results show that activation of 5-HT 2 receptors decreased GABA A receptor currents in PFC pyramidal neurons, which may provide a postsynaptic mechanism for an excitatory role of serotonin in PFC circuits. In serotonin deficit diseases (e.g., depression), the GABAergic inhibition in PFC may be over potent, leading to the decreased activity (hypoactivity). On the other hand, in serotonin excess diseases (e.g., anxiety), the GABAergic inhibition in PFC may be over suppressed, leading to the increased activity (hyperactivity). The serotonergic modulation of GABA A receptor functions is dependent on activation of the RACK1-anchored PKC. Elucidation of the signal transduction pathway engaged in serotonergic modulation of GABA A receptors raises the possibility that intracellular signaling components could be potential targets for novel pharmacological agents with greater therapeutic potential and fewer side effects in the treatment of neuropsychiatric disorders.
